Shanghai Micurx Pharmaceutical Co., Ltd. Class ASSE: 688373

Announcement on the Voluntary Disclosure of Acceptance of the New Drug Application for the Marketing Authorization of Contezolid Acefosamil Sodium for Injection

· Issued by Shanghai Micurx Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Voluntary Disclosure of Acceptance of the New Drug Application for the Marketing Authorization of Contezolid Acefosamil Sodium for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis